Sign Up to like & get
recommendations!
0
Published in 2017 at "Annals of Oncology"
DOI: 10.1093/annonc/mdx228
Abstract: Background In the open-label randomized phase III AURELIA trial, adding bevacizumab to chemotherapy for platinum-resistant ovarian cancer (PROC) significantly improved progression-free survival and response rate versus chemotherapy alone, but not overall survival (OS). We explored…
read more here.
Keywords:
chemotherapy;
platinum;
bevacizumab;
aurelia trial ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Immunotherapy"
DOI: 10.2217/imt-2022-0058
Abstract: Most advanced colorectal cancer patients with proficient DNA mismatch repair or microsatellite stability (MSS) are insensitive to immune checkpoint inhibitor therapy. This report describes a heavily pretreated refractory colon adenocarcinoma patient with MSS. After experiencing…
read more here.
Keywords:
bevacizumab chemotherapy;
long term;
sintilimab bevacizumab;
heavily pretreated ... See more keywords